These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28499793)

  • 1. Ciprofloxacin-loaded lipid-core nanocapsules as mucus penetrating drug delivery system intended for the treatment of bacterial infections in cystic fibrosis.
    Torge A; Wagner S; Chaves PS; Oliveira EG; Guterres SS; Pohlmann AR; Titz A; Schneider M; Beck RCR
    Int J Pharm; 2017 Jul; 527(1-2):92-102. PubMed ID: 28499793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections.
    Günday Türeli N; Torge A; Juntke J; Schwarz BC; Schneider-Daum N; Türeli AE; Lehr CM; Schneider M
    Eur J Pharm Biopharm; 2017 Aug; 117():363-371. PubMed ID: 28476373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections.
    Baelo A; Levato R; Julián E; Crespo A; Astola J; Gavaldà J; Engel E; Mateos-Timoneda MA; Torrents E
    J Control Release; 2015 Jul; 209():150-8. PubMed ID: 25913364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucus penetrating properties of soft, distensible lipid nanocapsules.
    Chen H; Mansfield EDH; Woods A; Khutoryanskiy VV; Forbes B; Jones SA
    Eur J Pharm Biopharm; 2019 Jun; 139():76-84. PubMed ID: 30818012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mannitol-guided delivery of Ciprofloxacin in artificial cystic fibrosis mucus model.
    Yang Y; Tsifansky MD; Shin S; Lin Q; Yeo Y
    Biotechnol Bioeng; 2011 Jun; 108(6):1441-9. PubMed ID: 21488050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of self-emulsifying drug delivery systems (SEDDS) for ciprofloxacin with improved mucus permeating properties.
    Zaichik S; Steinbring C; Menzel C; Knabl L; Orth-Höller D; Ellemunter H; Niedermayr K; Bernkop-Schnürch A
    Int J Pharm; 2018 Aug; 547(1-2):282-290. PubMed ID: 29883790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
    Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
    J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amikacin-containing self-emulsifying delivery systems via pulmonary administration for treatment of bacterial infections of cystic fibrosis patients.
    Hetényi G; Griesser J; Fontana S; Gutierrez AM; Ellemunter H; Niedermayr K; Szabó P; Bernkop-Schnürch A
    Nanomedicine (Lond); 2018 Apr; 13(7):717-732. PubMed ID: 29488425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the In Vitro Drug Release from Lipid-Core Nanocapsules: a New Strategy Combining Dialysis Sac and a Continuous-Flow System.
    de Andrade DF; Zuglianello C; Pohlmann AR; Guterres SS; Beck RC
    AAPS PharmSciTech; 2015 Dec; 16(6):1409-17. PubMed ID: 25986595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate-loaded lipid-core nanocapsules are highly effective in the control of inflammation in synovial cells and a chronic arthritis model.
    Boechat AL; de Oliveira CP; Tarragô AM; da Costa AG; Malheiro A; Guterres SS; Pohlmann AR
    Int J Nanomedicine; 2015; 10():6603-14. PubMed ID: 26543364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin-loaded lipid-core nanocapsules protect against lipid peroxidation caused by paraquat through increased SOD expression in Caenorhabditis elegans.
    Charão MF; Goethel G; Brucker N; Paese K; Eifler-Lima VL; Pohlmann AR; Guterres SS; Garcia SC
    BMC Pharmacol Toxicol; 2019 Dec; 20(Suppl 1):80. PubMed ID: 31852511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanocapsules for dermal application: a comparative study of lipid-based versus polymer-based nanocarriers.
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Eur J Pharm Biopharm; 2011 Sep; 79(1):36-42. PubMed ID: 21558002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium colistimethate loaded lipid nanocarriers for the treatment of Pseudomonas aeruginosa infections associated with cystic fibrosis.
    Pastor M; Moreno-Sastre M; Esquisabel A; Sans E; Viñas M; Bachiller D; Asensio VJ; Pozo AD; Gainza E; Pedraz JL
    Int J Pharm; 2014 Dec; 477(1-2):485-94. PubMed ID: 25445528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Two Types of Melatonin-Loaded Nanocapsules with Distinct Supramolecular Structures: Polymeric (NC) and Lipid-Core Nanocapsules (LNC) on Bovine Embryo Culture Model.
    Komninou ER; Remião MH; Lucas CG; Domingues WB; Basso AC; Jornada DS; Deschamps JC; Beck RC; Pohlmann AR; Bordignon V; Seixas FK; Campos VF; Guterres SS; Collares T
    PLoS One; 2016; 11(6):e0157561. PubMed ID: 27310006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.
    Tran TT; Vidaillac C; Yu H; Yong VFL; Roizman D; Chandrasekaran R; Lim AYH; Low TB; Tan GL; Abisheganaden JA; Koh MS; Teo J; Chotirmall SH; Hadinoto K
    Int J Pharm; 2018 Aug; 547(1-2):368-376. PubMed ID: 29886096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imipenem/cilastatin encapsulated polymeric nanoparticles for destroying carbapenem-resistant bacterial isolates.
    Shaaban MI; Shaker MA; Mady FM
    J Nanobiotechnology; 2017 Apr; 15(1):29. PubMed ID: 28399890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term coexistence of
    Monteiro R; Magalhães AP; Pereira MO; Sousa AM
    Future Microbiol; 2021 Aug; 16():879-893. PubMed ID: 34319132
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimization of ciprofloxacin complex loaded PLGA nanoparticles for pulmonary treatment of cystic fibrosis infections: Design of experiments approach.
    Günday Türeli N; Türeli AE; Schneider M
    Int J Pharm; 2016 Dec; 515(1-2):343-351. PubMed ID: 27744035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Antibiotic-loaded Point-of-care Implant Coating Inhibits Biofilm.
    Jennings JA; Carpenter DP; Troxel KS; Beenken KE; Smeltzer MS; Courtney HS; Haggard WO
    Clin Orthop Relat Res; 2015 Jul; 473(7):2270-82. PubMed ID: 25604874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyanion-tobramycin nanocomplexes into functional microparticles for the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.
    Craparo EF; Porsio B; Schillaci D; Cusimano MG; Spigolon D; Giammona G; Cavallaro G
    Nanomedicine (Lond); 2017 Jan; 12(1):25-42. PubMed ID: 27879162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.